---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-22-000053"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2022-06-14T23:59:59+00:00"
generated_at: "2026-06-25T02:05:13.898195+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sema4 CFO Isaac Ro to depart Aug. 9, 2022; Richard Miao named interim CFO

## Summary
- CFO Isaac Ro to leave Aug. 9, 2022; entitled to 9 months salary continuation and 12 months COBRA.
- Richard Miao, SVP of FP&A and Treasurer, promoted to Deputy CFO and Interim CFO effective June 13.
- Ro enters 6-month consulting agreement for advisory services with continued equity vesting.
- Company reaffirms financial guidance provided May 12, 2022; search for permanent CFO engaged via Russell Reynolds.
- Amendment extends Dr. Eric Schadt's 'Good Reason' notice period through April 28, 2023.

## SEC filing metadata
- accession: 0001818331-22-000053
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2022-06-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/smfr-20220610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-22-000053
- JSON: https://secwatch.observer/filing/0001818331-22-000053.json
- Plain text: https://secwatch.observer/filing/0001818331-22-000053.txt

## Key facts
- Executive change
  Isaac Ro resigned as Chief Financial Officer at GeneDx Holdings Corp..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: its Chief Financial Officer, Isaac Ro, will leave the Company to pursue other career opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm
- Executive change
  Richard Miao was appointed as Interim Chief Financial Officer at GeneDx Holdings Corp..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: Richard Miao, the Company’s current Senior Vice President of Financial Planning & Analysis and Treasurer, was promoted to Deputy Chief Financial Officer and appointed to serve as the Interim Chief Financial Officer, effective June 13, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.